Ghent University Academic Bibliography

Advanced

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

Maia Merabishvili UGent, Daniel De Vos, Gilbert Verbeken UGent, Andrew M Kropinski, Dieter Vandenheuvel, Rob Lavigne, Pierre Wattiau, Jan Mast, Catherine Ragimbeau, Joel Mossong, et al. (2012) PLOS ONE. 7(12).
abstract
In 2011, a novel strain of O104:H4 Escherichia coli caused a serious outbreak of foodborne hemolytic uremic syndrome and bloody diarrhea in Germany. Antibiotics were of questionable use and 54 deaths occurred. Candidate therapeutic bacteriophages that efficiently lyse the E. coli O104:H4 outbreak strain could be selected rather easily from a phage bank or isolated from the environment. It is argued that phage therapy should be more considered as a potential armament against the growing threat of (resistant) bacterial infections
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
PHAGE THERAPY
journal title
PLOS ONE
PLoS One
volume
7
issue
12
article number
e52709
pages
5 pages
Web of Science type
Article
Web of Science id
000313158800092
JCR category
MULTIDISCIPLINARY SCIENCES
JCR impact factor
3.73 (2012)
JCR rank
7/56 (2012)
JCR quartile
1 (2012)
ISSN
1932-6203
DOI
10.1371/journal.pone.0052709
language
English
UGent publication?
yes
classification
A1
copyright statement
I have retained and own the full copyright for this publication
id
3137249
handle
http://hdl.handle.net/1854/LU-3137249
date created
2013-02-20 15:21:53
date last changed
2016-12-21 15:42:29
@article{3137249,
  abstract     = {In 2011, a novel strain of O104:H4 Escherichia coli caused a serious outbreak of foodborne hemolytic uremic syndrome and bloody diarrhea in Germany. Antibiotics were of questionable use and 54 deaths occurred. Candidate therapeutic bacteriophages that efficiently lyse the E. coli O104:H4 outbreak strain could be selected rather easily from a phage bank or isolated from the environment. It is argued that phage therapy should be more considered as a potential armament against the growing threat of (resistant) bacterial infections},
  articleno    = {e52709},
  author       = {Merabishvili, Maia and De Vos, Daniel and Verbeken, Gilbert and Kropinski, Andrew M and Vandenheuvel, Dieter and Lavigne, Rob and Wattiau, Pierre and Mast, Jan and Ragimbeau, Catherine and Mossong, Joel and Scheres, Jacques and Chanishvili, Nina and Vaneechoutte, Mario and Pirnay, Jean-Paul},
  issn         = {1932-6203},
  journal      = {PLOS ONE},
  keyword      = {PHAGE THERAPY},
  language     = {eng},
  number       = {12},
  pages        = {5},
  title        = {Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany},
  url          = {http://dx.doi.org/10.1371/journal.pone.0052709},
  volume       = {7},
  year         = {2012},
}

Chicago
Merabishvili, Maia, Daniel De Vos, Gilbert Verbeken, Andrew M Kropinski, Dieter Vandenheuvel, Rob Lavigne, Pierre Wattiau, et al. 2012. “Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia Coli O104:H4 Strain from the 2011 Outbreak in Germany.” Plos One 7 (12).
APA
Merabishvili, Maia, De Vos, D., Verbeken, G., Kropinski, A. M., Vandenheuvel, D., Lavigne, R., Wattiau, P., et al. (2012). Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany. PLOS ONE, 7(12).
Vancouver
1.
Merabishvili M, De Vos D, Verbeken G, Kropinski AM, Vandenheuvel D, Lavigne R, et al. Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany. PLOS ONE. 2012;7(12).
MLA
Merabishvili, Maia, Daniel De Vos, Gilbert Verbeken, et al. “Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia Coli O104:H4 Strain from the 2011 Outbreak in Germany.” PLOS ONE 7.12 (2012): n. pag. Print.